- Home
- CRBP vs RDNW Comparison
CRBP vs RDNW Comparison
Compare CRBP & RDNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- RDNW
- Stock Information
- Founded
- CRBP 2009
- RDNW 2013
- Country
- CRBP United States
- RDNW United States
- Employees
- CRBP N/A
- RDNW N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- RDNW EDP Services
- Sector
- CRBP Health Care
- RDNW Technology
- Exchange
- CRBP Nasdaq
- RDNW Nasdaq
- Market Cap
- CRBP 210.8M
- RDNW 202.9M
- IPO Year
- CRBP N/A
- RDNW N/A
- Fundamental
- Price
- CRBP $11.23
- RDNW $5.19
- Analyst Decision
- CRBP Strong Buy
- RDNW Hold
- Analyst Count
- CRBP 9
- RDNW 1
- Target Price
- CRBP $48.38
- RDNW $4.00
- AVG Volume (30 Days)
- CRBP 546.2K
- RDNW 59.6K
- Earning Date
- CRBP 11-12-2025
- RDNW 11-04-2025
- Dividend Yield
- CRBP N/A
- RDNW N/A
- EPS Growth
- CRBP N/A
- RDNW N/A
- EPS
- CRBP N/A
- RDNW N/A
- Revenue
- CRBP N/A
- RDNW $1,095,200,000.00
- Revenue This Year
- CRBP N/A
- RDNW N/A
- Revenue Next Year
- CRBP $220.00
- RDNW $7.73
- P/E Ratio
- CRBP N/A
- RDNW N/A
- Revenue Growth
- CRBP N/A
- RDNW N/A
- 52 Week Low
- CRBP $4.64
- RDNW $1.46
- 52 Week High
- CRBP $20.56
- RDNW $7.06
- Technical
- Relative Strength Index (RSI)
- CRBP 38.90
- RDNW N/A
- Support Level
- CRBP $10.88
- RDNW N/A
- Resistance Level
- CRBP $12.43
- RDNW N/A
- Average True Range (ATR)
- CRBP 0.76
- RDNW 0.00
- MACD
- CRBP 0.05
- RDNW 0.00
- Stochastic Oscillator
- CRBP 51.59
- RDNW 0.00
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About RDNW RideNow Group Inc.
RideNow Group Inc is a USA-based online retailer that allows consumers and dealers both to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience.